Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics.
Welter L, Zheng S, Setayesh SM, Morikado M, Agrawal A, Nevarez R, Naghdloo A, Pore M, Higa N, Kolatkar A, Thiele JA, Sharma P, Moore HCF, Richer JK, Elias A, Pienta KJ, Zurita AJ, Gross ME, Shishido SN, Hicks J, Velasco CR, Kuhn P. Welter L, et al. Among authors: richer jk. Cancers (Basel). 2023 Aug 3;15(15):3949. doi: 10.3390/cancers15153949. Cancers (Basel). 2023. PMID: 37568766 Free PMC article.
Anti-androgen therapy in triple-negative breast cancer.
Barton VN, Gordon MA, Richer JK, Elias A. Barton VN, et al. Among authors: richer jk. Ther Adv Med Oncol. 2016 Jul;8(4):305-8. doi: 10.1177/1758834016646735. Epub 2016 May 31. Ther Adv Med Oncol. 2016. PMID: 27482289 Free PMC article. No abstract available.
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer.
O'Neill KI, Kuo LW, Williams MM, Lind H, Crump LS, Hammond NG, Spoelstra NS, Caino MC, Richer JK. O'Neill KI, et al. Among authors: richer jk. Cancers (Basel). 2022 Jul 21;14(14):3543. doi: 10.3390/cancers14143543. Cancers (Basel). 2022. PMID: 35884604 Free PMC article.
Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance.
Harvell DM, Spoelstra NS, Singh M, McManaman JL, Finlayson C, Phang T, Trapp S, Hunter L, Dye WW, Borges VF, Elias A, Horwitz KB, Richer JK. Harvell DM, et al. Among authors: richer jk. Breast Cancer Res Treat. 2008 Dec;112(3):475-88. doi: 10.1007/s10549-008-9897-4. Epub 2008 Mar 9. Breast Cancer Res Treat. 2008. PMID: 18327671 Clinical Trial.
Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor.
Harvell DM, Richer JK, Singh M, Spoelstra N, Finlayson C, Borges VF, Elias AD, Horwitz KB. Harvell DM, et al. Among authors: richer jk. Breast Cancer Res Treat. 2008 Dec;112(3):489-501. doi: 10.1007/s10549-008-9923-6. Epub 2008 Mar 13. Breast Cancer Res Treat. 2008. PMID: 18338247
103 results